Drug interactions
Indacaterol-glycopyrronium + Octreotide
Severity: Moderate
Indacaterol-glycopyrronium and Octreotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Octreotide can cause bradycardia and has been associated with QT prolongation, while inhaled indacaterol can lengthen the QT interval at higher exposures. Using them together may modestly raise the chance of ventricular arrhythmia, especially with electrolyte disturbances or heart disease.
What this interaction means in plain words
Indacaterol-glycopyrronium and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Indacaterol-glycopyrronium belongs to Respiratory; Octreotide belongs to Endocrine.
Why it happens
Additive effects on cardiac repolarization and heart rate (QT prolongation by beta-2 agonist stimulation and octreotide-related conduction effects).
What to do
Obtain a baseline ECG in patients with cardiac risk factors and correct potassium and magnesium. Monitor heart rate and QTc after starting or changing either drug.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Octreotide
Frequently asked questions
Can I take Indacaterol-glycopyrronium with Octreotide?
MediHelp rates the interaction as moderate. Indacaterol-glycopyrronium and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Octreotide can cause bradycardia and has been associated with QT prolongation, while inhaled indacaterol can lengthen the QT interval at higher exposures. Using them together may modestly raise the chance of ventricular arrhythmia, especially with electrolyte disturbances or heart disease.
How serious is the interaction between Indacaterol-glycopyrronium and Octreotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG in patients with cardiac risk factors and correct potassium and magnesium. Monitor heart rate and QTc after starting or changing either drug.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
